Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Zalcberg

Showing results (51-60 of 151) with videos related to

Pageof 16
Sort By:
European Journal of Cancer Care|May 6, 2022
The SYMPTOM-upper gastrointestinal study: A mixed methods study exploring symptom appraisal and help-seeking in Australian upper gastrointestinal cancer patientsNapin Karnchanachari, Shakira Milton, Tjuntu Muhlen-Schulte, et al.
ERJ Open Research|May 28, 2021
Excess mortality and undertreatment in elderly lung cancer patients: treatment nihilism in the modern era?Jonathan Pham, Matthew Conron, Gavin Wright, et al.
Health and Quality of Life Outcomes|June 1, 2021
Measurement properties of the 12-item Short Form Health Survey version 2 in Australians with lung cancer: a Rasch analysisSze-Ee Soh, Renata Morello, Darshini Ayton, et al.
Clinical Colorectal Cancer|September 2, 2006
Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicityPaul L Mitchell, David Goldstein, Michael Michael, et al.
Investigational New Drugs|January 24, 2004
A novel combination of cisplatin, irinotecan, and capecitabine in patients with advanced cancerMichael Jefford, Michael Michael, Mark A Rosenthal, et al.
Asia-Pacific Journal of Clinical Oncology|March 29, 2014
Controversies in the management of gastrointestinal stromal tumorsDesmond Yip, John Zalcberg, Stephen Ackland, et al.
Gynecologic Oncology|July 23, 2025
Perioperative outcomes after interval cytoreductive surgery and primary cytoreductive surgery for advanced epithelial ovarian cancer in Australia: A National Gynae-Oncology Registry (NGOR) studyMonica McGauran, Simon Hyde, Sharnel Perera, et al.
ANZ Journal of Surgery|June 11, 2026
Stakeholder Consensus Selection of Data Elements and Indicators for a Pancreatic Cancer Surgical Outcomes Registry in Australia and Aotearoa New Zealand: Modified Delphi ProcessElizabeth Lockie, Anita Skandarajah, John Zalcberg, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2021
Impacts of lung cancer multidisciplinary meeting presentation: Drivers and outcomes from a population registry retrospective cohort studyTiffany Lin, Jonathan Pham, Eldho Paul, et al.
Frontiers in Oncology|December 27, 2021
EUS-FNA Biopsies to Guide Precision Medicine in Pancreatic Cancer: Results of a Pilot Study to Identify <i>KRAS</i> Wild-Type Tumours for Targeted TherapyJoanne Lundy, Marion Harris, John Zalcberg, et al.
Pageof 16

Showing results (51-60 of 151) with videos related to

Sort By:
Pageof 16
European Journal of Cancer Care|May 6, 2022
The SYMPTOM-upper gastrointestinal study: A mixed methods study exploring symptom appraisal and help-seeking in Australian upper gastrointestinal cancer patientsNapin Karnchanachari, Shakira Milton, Tjuntu Muhlen-Schulte, et al.
ERJ Open Research|May 28, 2021
Excess mortality and undertreatment in elderly lung cancer patients: treatment nihilism in the modern era?Jonathan Pham, Matthew Conron, Gavin Wright, et al.
Health and Quality of Life Outcomes|June 1, 2021
Measurement properties of the 12-item Short Form Health Survey version 2 in Australians with lung cancer: a Rasch analysisSze-Ee Soh, Renata Morello, Darshini Ayton, et al.
Clinical Colorectal Cancer|September 2, 2006
Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicityPaul L Mitchell, David Goldstein, Michael Michael, et al.
Investigational New Drugs|January 24, 2004
A novel combination of cisplatin, irinotecan, and capecitabine in patients with advanced cancerMichael Jefford, Michael Michael, Mark A Rosenthal, et al.
Asia-Pacific Journal of Clinical Oncology|March 29, 2014
Controversies in the management of gastrointestinal stromal tumorsDesmond Yip, John Zalcberg, Stephen Ackland, et al.
Gynecologic Oncology|July 23, 2025
Perioperative outcomes after interval cytoreductive surgery and primary cytoreductive surgery for advanced epithelial ovarian cancer in Australia: A National Gynae-Oncology Registry (NGOR) studyMonica McGauran, Simon Hyde, Sharnel Perera, et al.
ANZ Journal of Surgery|June 11, 2026
Stakeholder Consensus Selection of Data Elements and Indicators for a Pancreatic Cancer Surgical Outcomes Registry in Australia and Aotearoa New Zealand: Modified Delphi ProcessElizabeth Lockie, Anita Skandarajah, John Zalcberg, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2021
Impacts of lung cancer multidisciplinary meeting presentation: Drivers and outcomes from a population registry retrospective cohort studyTiffany Lin, Jonathan Pham, Eldho Paul, et al.
Frontiers in Oncology|December 27, 2021
EUS-FNA Biopsies to Guide Precision Medicine in Pancreatic Cancer: Results of a Pilot Study to Identify <i>KRAS</i> Wild-Type Tumours for Targeted TherapyJoanne Lundy, Marion Harris, John Zalcberg, et al.
Pageof 16